What is Strella Biotechnology?
Strella Biotechnology operates at the intersection of biotechnology and supply chain logistics, providing actionable data to optimize the fresh produce industry. The company utilizes proprietary biosensor technology to deliver dynamic shelf-life predictions, effectively reducing shrink and increasing margins for produce distributors. By integrating IoT-driven insights into the cold chain, Strella Biotech addresses the critical need for transparency and quality control in perishable goods management. Their market position is defined by a commitment to reducing carbon emissions and enhancing sustainability, positioning the firm as a vital player in the global effort to modernize food distribution networks through data-driven precision.
How much funding has Strella Biotechnology raised?
Strella Biotechnology has raised a total of $13.1M across 3 funding rounds:
Angel/Seed
$3.3M
Series A
$8M
Stock/Share Issuance
$1.8M
Angel/Seed (2020): $3.3M with participation from Yamaha Motor Ventures & Laboratory Silicon Valley Inc
Series A (2022): $8M led by Catapult Ventures, Millennium New Horizons, GV, Rich Products Ventures, Union Labs, and Yamaha Motor Ventures
Stock/Share Issuance (2026): $1.8M, investors not publicly disclosed
Key Investors in Strella Biotechnology
Catapult Ventures
Catapult Ventures specializes in providing tailored investment solutions to meet the funding needs of entrepreneurs and business owners, focusing on unlocking potential and fostering long-term growth.
GV
GV is a prominent venture capital firm that invests across multiple stages and sectors, including enterprise solutions, life sciences, and frontier technology innovations.
Yamaha Motor Ventures
Yamaha Motor Ventures focuses on strategic investments in emerging technologies that align with industrial innovation, mobility, and sustainable supply chain solutions.
What's next for Strella Biotechnology?
With the recent influx of capital, Strella Biotechnology is well-positioned to transition into a broader enterprise-level operational phase. The strategic roadmap likely involves expanding the deployment of its biosensor arrays across international supply chains and refining its predictive analytics engine to handle larger datasets. As the company scales, the focus will shift toward deepening integration with major retail and logistics partners, further cementing its role as an essential utility for waste reduction. The firm's ability to demonstrate measurable ROI through reduced spoilage will be critical in maintaining its growth trajectory and securing its status as a leader in the ag-tech sector.
See full Strella Biotechnology company page
